ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SAMUEL OLOYO M.D.

Internal Medicine

22,383

$1.5M

519
338 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

48%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $67

JOSE PORRAS MD

Internal Medicine

21,269

$1.49M

761
636 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

NORMA RIVERA-OPIO M.D.

Internal Medicine

21,044

$1.47M

988
773 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

ORVILLE CERNA M.D.

Internal Medicine

24,903

$1.46M

893
732 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

JULIO SAVINON M.D., P.A.

Internal Medicine

19,070

$1.43M

1142
939 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $67

DAVID LEE MD

Internal Medicine

3,879

$1.43M

158
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 27%

$369
Average prescription price

Avg: $67

MARVIN MOSZKOWICZ M.D.

Internal Medicine

22,050

$1.42M

625
564 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $67

SANJEEV BHATIA M.D.

Internal Medicine

22,214

$1.41M

769
509 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $67

FIROOZEH KAR M.D.

Internal Medicine

24,815

$1.4M

508
446 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

GABRIELA HUNKO M.D.

Internal Medicine

16,753

$1.4M

1152
947 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$84
Average prescription price

Avg: $67

SUNG LIM MD

Internal Medicine

12,775

$1.39M

930
738 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 27%

$109
Average prescription price

Avg: $67

SAMUEL ROMERO-RAMOS M.D.

Internal Medicine

13,297

$1.38M

672
562 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$104
Average prescription price

Avg: $67

ADONIS ZUNIGA GOLDWATER MD

Internal Medicine

17,379

$1.37M

765
652 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $67

IRINA MININA M.D

Internal Medicine

18,231

$1.37M

851
690 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $67

ZAHID ZAFAR M.D.

Internal Medicine

24,917

$1.36M

1105
925 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

MICHAEL FLORES MD

Internal Medicine

18,473

$1.36M

579
417 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$74
Average prescription price

Avg: $67

JITENDRA BHATT M D

Internal Medicine

25,043

$1.36M

778
654 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

BLAS MIRANDA M.D.

Internal Medicine

18,797

$1.35M

1345
1097 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $67

ROBERT CHING DO

Internal Medicine

18,907

$1.35M

697
454 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $67

JORGE GUEVARA MD

Internal Medicine

20,542

$1.35M

863
689 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $67

DAVID KUBAN D.O.

Internal Medicine

23,326

$1.35M

740
673 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

NORMAN DAVENPORT MD

Internal Medicine

22,084

$1.34M

851
795 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

TRAM HO MD

Internal Medicine

15,348

$1.34M

751
654 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$87
Average prescription price

Avg: $67

SUNDEEP REDDY M.D.

Internal Medicine

14,468

$1.34M

945
761 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$93
Average prescription price

Avg: $67

RICARDO CARRIZO MD

Internal Medicine

17,573

$1.34M

533
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$76
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank